MAO-inhibitory properties of anorectic drugs.
D000818:Animals; D001067:Appetite Depressants / Q000494:pharmacology*; D002745:Chlorphentermine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000201:enzymology; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D008168:Lung / Q000201:enzymology; D008784:Methysergide / Q000494:pharmacology; D008930:Mitochondria, Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D010645:Phentermine / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists
D001067:Appetite Depressants; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D012702:Serotonin Antagonists; D010645:Phentermine; D007490:Iproniazid; D002745:Chlorphentermine; D010633:Phenmetrazine; D008784:Methysergide